UNSPSC 51131520: Plerixafor

This classification denotes a chemokine receptor antagonist and antiviral agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S915P5499N. European Medicines Agency schedules Plerixafor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB28849. Plerixafor generally arises in the molecular formula C28H54N8.

UNSPSC 51131520 Plerixafor is a Commodity code that shows no relevant recent state and local procurement activity. The single recent opportunity tagged to this code — Sourcewell RFP #061626, posted May 12, 2026 with a response deadline of June 16, 2026 — solicits law enforcement equipment on behalf of multiple Washington counties and other jurisdictions through a cooperative purchasing vehicle, which bears no relation to plerixafor, a pharmaceutical agent used in stem cell mobilization. The mismatch indicates either a cataloging error in the source or that the code is not actively used by state and local buyers for its intended pharmaceutical scope.

State and local procurement activity under plerixafor may exist but does not appear in recent opportunity records available through standard channels. Healthcare purchasers—state health departments, county health agencies, and hospital systems—would be the expected buyers if activity were present, but no such solicitations are reflected in the recent postings. Absence of activity in this Commodity code warrants monitoring of state Medicaid formulary procurement cycles and specialty pharmaceutical RFQs, but current signals do not support near-term pursuit under this code designation.